C

Citius Oncology Inc
NASDAQ:CTOR

Watchlist Manager
Citius Oncology Inc
NASDAQ:CTOR
Watchlist
Price: 1.145 USD -9.84% Market Closed
Market Cap: 95.6m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CTOR.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CTOR Intrinsic Value
Not Available
Base Case Scenario
Compare CTOR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CTOR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Citius Oncology Inc

Balance Sheet Decomposition
Citius Oncology Inc

Current Assets 18.3m
Other Current Assets 18.3m
Non-Current Assets 73.4m
Intangibles 73.4m
Current Liabilities 53m
Accounts Payable 8.7m
Accrued Liabilities 8.5m
Other Current Liabilities 35.9m
Non-Current Liabilities 6.3m
Long-Term Debt 3.8m
Other Non-Current Liabilities 2.5m
Efficiency

Free Cash Flow Analysis
Citius Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Citius Oncology Inc

Revenue
0 USD
Operating Expenses
-38.8m USD
Operating Income
-38.8m USD
Other Expenses
-3m USD
Net Income
-41.8m USD
Fundamental Scores

CTOR Profitability Score
Profitability Due Diligence

Citius Oncology Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
hidden
Profitability
Score

Citius Oncology Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CTOR Solvency Score
Solvency Due Diligence

Citius Oncology Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Citius Oncology Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTOR Price Targets Summary
Citius Oncology Inc

Wall Street analysts forecast CTOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTOR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
429% Upside
Average
Price Target
6.12 USD
434% Upside
Highest
Price Target
6.3 USD
450% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Citius Oncology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CTOR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y